SEQENSgroup
SEQENS is adapting its prices in order to secure its supply chain and customer services in the face of an unprecedented situation of rising…
Read moreSEQENS, world leader in pharmaceutical synthesis and specialty ingredients, inaugurates its pharmaceutical quality control laboratory on its salicylic acid production site in Roussillon…
Read moreDID YOU KNOW? The applications of our products contribute to some of the 17 United Nations Sustainable Development Goals (SDGs). SDG 6: Ensure…
Read moreFive years after its entry into the capital of SEQENS, Eurazeo announces that it has entered into exclusive discussions to sell its stake in…
Read moreDID YOU KNOW? The applications of our products contribute to some of the 17 United Nations Sustainable Development Goals (SDGs).
Read moreSeqens held on 8 June 2021 its 2nd Scientific Commitee. On this occasion, our new solid state capabilities and services addressing our customers’s…
Read moreThe Labcom HitCat (High-Throughput Catalysis center) was inaugurated in partnership with the CNRS in the Seqens’Lab. Their common objective is to develop innovative…
Read moreAfter a full year of R&D studies, SEQENS has officially launched the project to build a new paracetamol production unit, in partnership with…
Read moreAcetylSalicylic Acid (ASA better known as Aspirin) is one of the most popular Non-Steroidal Anti-Inflammatory Drugs (NSAID) in the world. First used…
Read moreProfessor Patrick Couvreur, Emeritus Professor of Pharmacy at Paris-Saclay University, has a world-renowned expertise in the design of new nanomedicines for the treatment…
Read more